124 related articles for article (PubMed ID: 30719124)
1. The Radiosensitization of Sodium Glycididazole on Nasopharyngeal Carcinoma Cells via Enhancing DNA Damage and Promoting Apoptosis.
Min X; Huang F; Huang H; Zhao S; Wang G; Zhou M; Chen Z; Li M; Chen Y
J Cancer; 2019; 10(2):305-312. PubMed ID: 30719124
[No Abstract] [Full Text] [Related]
2. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
[TBL] [Abstract][Full Text] [Related]
3. Glycididazole sodium combined with radiochemotherapy for locally advanced nasopharyngeal carcinoma.
Li MY; Liu JQ; Chen DP; Qi B; Liang YY; Yin WJ
Asian Pac J Cancer Prev; 2014; 15(6):2641-6. PubMed ID: 24761877
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hypoxia status with radiosensitizing effects of sodium glycididazole: A preclinical study.
Yu Y; Li X; Xu H; Liu J; Dong M; Yang J; Sun L; Sun X; Xing L
Oncol Lett; 2018 May; 15(5):6481-6488. PubMed ID: 29616117
[TBL] [Abstract][Full Text] [Related]
5. Enhanced radiosensitizing by sodium glycididazole in a recurrent esophageal carcinoma tumor model.
Wu P; Liu J; Sun X; Li X; Xing L; Yu J
Oncotarget; 2017 Sep; 8(38):63871-63880. PubMed ID: 28969036
[TBL] [Abstract][Full Text] [Related]
6. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
Chang L; Huang J; Wang K; Li J; Yan R; Zhu L; Ye J; Wu X; Zhuang S; Li D; Zhang G
BMC Cancer; 2016 Mar; 16():190. PubMed ID: 26951044
[TBL] [Abstract][Full Text] [Related]
7. NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway.
Li H; Chen X; Yu Y; Wang Z; Zuo Y; Li S; Yang D; Hu S; Xiang M; Xu Z; Yu Z
Oncol Rep; 2014 Dec; 32(6):2596-604. PubMed ID: 25333332
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
[TBL] [Abstract][Full Text] [Related]
10. [Concurrent chemoradiotherapy with sodium glycididazole and cisplatin for local advanced nasopharyngeal carcinoma].
He ZY; Li FY; Tong Q; Liao ZW; Guan XX; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2038-40. PubMed ID: 19033122
[TBL] [Abstract][Full Text] [Related]
11. Effect of CMNa combined with radiotherapy on the tumor immune microenvironment of mouse cervical cancer cell transplantation tumor model.
Li L; Shi W; Zhou J
Bioengineered; 2021 Dec; 12(1):1066-1077. PubMed ID: 33784955
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells.
Li Z; Li N; Shen L; Fu J
Front Oncol; 2018; 8():548. PubMed ID: 30524968
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Annexin A1 is correlated with radioresistance in nasopharyngeal carcinoma.
Huang L; Liao L; Wan Y; Cheng A; Li M; Chen S; Li M; Tan X; Zeng G
Oncol Lett; 2016 Dec; 12(6):5229-5234. PubMed ID: 28101240
[TBL] [Abstract][Full Text] [Related]
14. Glycididazole sodium combined with radioiodine therapy for patients with differentiated thyroid carcinoma (DTC).
Wen Q; Ma Q; Bai L; Wang T; Han Y; Zhang H
Int J Clin Exp Med; 2015; 8(8):14095-9. PubMed ID: 26550375
[TBL] [Abstract][Full Text] [Related]
15. Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21.
Wu C; Guo E; Ming J; Sun W; Nie X; Sun L; Peng S; Luo M; Liu D; Zhang L; Mei Q; Long G; Hu G; Hu G
Mol Ther Oncolytics; 2020 Jun; 17():306-319. PubMed ID: 32382655
[TBL] [Abstract][Full Text] [Related]
16. Influence of POLG on Radiosensitivity of Nasopharyngeal Carcinoma Cells.
Chen R; Wang Z; Lan R; Huang F; Chen J; Xu Y; Zhang H; Zhang L
Cancer Biother Radiopharm; 2018 May; 33(4):146-154. PubMed ID: 29763377
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma.
Chen W; Hu GH
Cancer Biol Med; 2015 Mar; 12(1):23-32. PubMed ID: 25859408
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
[TBL] [Abstract][Full Text] [Related]
19. Slug inhibition increases radiosensitivity of nasopharyngeal carcinoma cell line C666-1.
Yang H; Zhang G; Che X; Yu S
Exp Ther Med; 2018 Apr; 15(4):3477-3482. PubMed ID: 29545871
[TBL] [Abstract][Full Text] [Related]
20. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
